CClinicalTrials.gg
CompletedNCT02689154Updated Apr 12, 2019Results posted

W8Loss2Go: mHealth Weight Management Strategy

An interventional study of W8Loss2Go in Obesity, sponsored by Children's Hospital Los Angeles. Completed at 1 site in United States. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2019-04-12.

Sponsored by Children's Hospital Los Angeles · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Not applicable
Ages
12 Years to 18 Years
Sex
All
01

Study summary

The investigators will test a recent mobile technology based (mHealth) behavioral weight loss intervention (W8Loss2Go), which is designed for children and adolescents, and uses an addiction model to promote withdrawal from problem foods, snacking, and excessive amounts at meals. The investigators will test whether this intervention will reduce body mass index (BMI), help subjects identify and withdraw from "problem foods", eliminate snacking, and reduce the amounts of foods consumed at home meals.

Read the detailed description

Background and Rationale: About one in five 12-18 year-olds in the U.S. are obese. It has been theorized that overeating in some individuals may have addictive qualities, and that specific foods may have addictive potential for these people. But few weight management interventions have tested therapeutic techniques founded in addiction medicine principles to date. Since mHealth interventions have been successful in the treatment of other addictions, the investigators hypothesize that mHealth technologies which are rooted in behavioral theory could be effective to promote weight loss in some individuals.

Dr. Robert Pretlow, together with E-Health International, created a weight loss intervention via an iPhone application (W8Loss2Go), based on the addiction treatment approach of staged, incremental withdrawal from problem foods, snacking/grazing, and excessive amounts of foods at meals. The W8Loss2Go application helps participants address their dependence on specific problem foods prior to addressing the amount of food consumed. A secondary focus of the application is to increase the amount of health provider-patient interaction outside of clinic based face-to-face-sessions in a cost-effective manner. Initial pilot studies in obese adolescents in a community setting showed success in improving these problem behaviors and improving BMI.

Intervention: The investigators will test a recent mobile technology based (mHealth) behavioral weight loss intervention, W8Loss2Go, which is designed for children and adolescents, and uses an addiction model to promote a staged withdrawal from problem foods, snacking, and excessive amounts at meals.

Hypothesis: The investigators hypothesize that participants who display addictive behaviors will respond well the mHealth intervention and will be able to withdraw from problem foods and eliminate snacking and excessive amounts eaten at meals, and will therefore show significant decrease in BMI z score from first to last visit.

Specific Aim 1: Determine if participants utilizing the app can stop eating certain self-identified problem foods.

Specific Aim 2: Determine if participants utilizing the app can reduce the amounts (portion-size and frequency) of foods that they consume in large quantities.

Study Design: New EMPOWER patients complete the Yale Food Addiction Study for Children (YFAS-c), a validated 25 item instrument designed to identify addictive behaviors related to food. Patients with more than two positive criteria on the YFAS-C will be recruited for participation in the W8Loss2Go study. Enrolled subjects and their parents will complete the Eating Behaviors Questionnaire (EBQ-Merlo 2009), and then receive the app, an iPhone 5S (if needed), a wireless body weight scale, and a wireless food scale. Over the next 6 months, subjects will proceed through all parts of the app program (problem food withdrawal, snacking control and withdrawal from excessive portions) and receive weekly phone calls from the study coordinator, who will be monitoring app usage and providing motivation. During the six months study period, subjects will return to the EMPOWER clinic for a three month weight check and face-to face meeting with their mentor. After the study period, participants will again complete the EBQ, and be offered continued enrollment in the EMPOWER clinic or continued home use of the mHealth technology Study Population: Twenty obese 12-18 year old adolescents will be recruited from new patients referred to the CHLA EMPOWER Clinic.

Control Population: The investigators will utilize historical controls using newly referred patients to the EMPOWER clinic who score negative on the YFAS-c.

Methods of Data Analysis: All outcome variables will be compared before and after the intervention using paired t-tests. Further analysis will compare the results of the W8Loss2Go program to the contemporary anthropomorphic changes in patients undergoing standard care in our EMPOWER program, using two sample t-tests.

Significance: This study will evaluate the feasibility of implementing a mHealth intervention in a large clinic setting and further explore the role of food addiction specific weight loss therapies as an effective and sustainable weight management strategy for children and adolescents.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • Pediatric Obesity
  • Food Addiction
  • Mobile Health (mHealth)
  • Weight Management
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 18 is below the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Children's Hospital Los Angeles is the lead sponsor of 150 studies on the registry; 46 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age 12-18 years
  2. Patients referred to EMPOWER
  3. Positive screen on the Yale Food Addiction Scale for Children
  4. Participant will not be leaving the country during the study duration.

Exclusion criteria

Exclusion Criteria:

  1. Obesity comorbidities including impaired glucose tolerance, impaired fasting glucose, diabetes, fatty liver with ALT>40, BP > 99th percentile for age, gender, and height
  2. Psychiatric illness including depression and anxiety disorder
  3. Known developmental delay
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
18 participants (actual)

Study arms

  • Experimental
    W8Loss2Go App

    Subjects will complete all stages of W8Loss2Go mHealth intervention.

    Device: W8Loss2Go

Interventions

  • DeviceW8Loss2Go

    The participants will proceed through all parts of the app program (problem food withdrawal, snacking control and withdrawal from excessive portions) and receive weekly phone calls from the study coordinator, who will be monitoring app usage and providing motivation. Subjects will return to the EMPOWER clinic for a three month weight check and face-to-face meeting with their mentor. After the study period, participants will again complete the EBQ, and be offered continued enrollment in the EMPOWER clinic or continued home use of the mHealth technology.

06

What researchers measure

Primary outcomes

  1. Body Mass Index (BMI) z -Score

    The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in BMI or a better outcome and a positive change value reflects an increase in BMI or a worsening in the outcome.

    Time frame: Baseline and 6 months

Secondary outcomes

  1. Number of Participants With Success in Withdrawing From Problem Foods

    The number of participants who were able to withdraw from 5 or more problem foods was evaluated.

    Time frame: 6 months

  2. Number of Participants Able to Eliminated Day Time Snacking

    Success in these areas will be determined by data collected from within the application's database.

    Time frame: 3 months

  3. Number of Participants Able to Reduce Daily Meal Portion Size Utilizing Wireless Food Scale.

    Success in these areas will be determined by data collected from within the application's database. Participants will weight meals daily and the app will assist the participant in decrease the quantity of food consumed each day until they achieve age appropriate portion size.

    Time frame: 1 month

07

Results

Posted Apr 12, 2019
Limitations and caveats
Although these results are encouraging, there are limitations to interpreting these results as they arise from a small, time limited, pilot study.

Participant flow

18 adolescents self-selected into the app intervention. During the intervention period the app participants did not attend the EMPOWER intervention. The app program did not require parental involvement.

Participant flow — Overall Study
MilestoneW8Loss2Go App
Started18
Completed18
Not completed0

Outcome measures

PrimaryBody Mass Index (BMI) z -Score

The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in BMI or a better outcome and a positive change value reflects an increase in BMI or a worsening in the outcome.

Time frame:
Baseline and 6 months
Reported as:
Mean · z-score
Body Mass Index (BMI) z -Score
z-scoreW8Loss2Go App
Body Mass Index (BMI) z -Score-0.1 ± 0.04
SecondaryNumber of Participants With Success in Withdrawing From Problem Foods

The number of participants who were able to withdraw from 5 or more problem foods was evaluated.

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Participants With Success in Withdrawing From Problem Foods
ParticipantsW8Loss2Go App
Number of Participants With Success in Withdrawing From Problem Foods18
SecondaryNumber of Participants Able to Eliminated Day Time Snacking

Success in these areas will be determined by data collected from within the application's database.

Time frame:
3 months
Reported as:
Count of participants · Participants
Number of Participants Able to Eliminated Day Time Snacking
ParticipantsW8Loss2Go App
Number of Participants Able to Eliminated Day Time Snacking18
SecondaryNumber of Participants Able to Reduce Daily Meal Portion Size Utilizing Wireless Food Scale.

Success in these areas will be determined by data collected from within the application's database. Participants will weight meals daily and the app will assist the participant in decrease the quantity of food consumed each day until they achieve age appropriate portion size.

Time frame:
1 month
Reported as:
Count of participants · Participants
Number of Participants Able to Reduce Daily Meal Portion Size Utilizing Wireless Food Scale.
ParticipantsW8Loss2Go App
Number of Participants Able to Reduce Daily Meal Portion Size Utilizing Wireless Food Scale.18

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
W8Loss2Go App0/18 (0%)0/18 (0%)0/18 (0%)

Baseline characteristics

Of the 50 eligible adolescents approached, 18 elected to participate in the app intervention

Age, Categorical
Age, Categorical(Participants)W8Loss2Go App
<=18 years18
Between 18 and 65 years0
>=65 years0
Age, Continuous
Age, Continuous(years)W8Loss2Go App
Median14.44 ± 1.65
Sex: Female, Male
Sex: Female, Male(Participants)W8Loss2Go App
Female13
Male5
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)W8Loss2Go App
Hispanic or Latino11
Not Hispanic or Latino7
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)W8Loss2Go App
United States18
zBMI
zBMI(z-score)W8Loss2Go App
Mean2.21 ± 0.45
08

Study locations

1 site
  • Children's Hospital of Los Angeles
    Los Angeles, California 90027, United States
09

References and documents

Publications

  • Chaplais E, Naughton G, Thivel D, Courteix D, Greene D. Smartphone Interventions for Weight Treatment and Behavioral Change in Pediatric Obesity: A Systematic Review. Telemed J E Health. 2015 Oct;21(10):822-30. doi: 10.1089/tmj.2014.0197. Epub 2015 Aug 20. PubMed 26290954 ↗
  • Dimitrijevic I, Popovic N, Sabljak V, Skodric-Trifunovic V, Dimitrijevic N. Food addiction-diagnosis and treatment. Psychiatr Danub. 2015 Mar;27(1):101-6. PubMed 25751444 ↗
  • Lin PH, Intille S, Bennett G, Bosworth HB, Corsino L, Voils C, Grambow S, Lazenka T, Batch BC, Tyson C, Svetkey LP. Adaptive intervention design in mobile health: Intervention design and development in the Cell Phone Intervention for You trial. Clin Trials. 2015 Dec;12(6):634-45. doi: 10.1177/1740774515597222. Epub 2015 Jul 30. PubMed 26229119 ↗
  • Delisle C, Sandin S, Forsum E, Henriksson H, Trolle-Lagerros Y, Larsson C, Maddison R, Ortega FB, Ruiz JR, Silfvernagel K, Timpka T, Lof M. A web- and mobile phone-based intervention to prevent obesity in 4-year-olds (MINISTOP): a population-based randomized controlled trial. BMC Public Health. 2015 Feb 7;15:95. doi: 10.1186/s12889-015-1444-8. PubMed 25886009 ↗
  • Gearhardt AN, Corbin WR. The role of food addiction in clinical research. Curr Pharm Des. 2011;17(12):1140-2. doi: 10.2174/138161211795656800. PubMed 21492090 ↗
  • Jeon E, Park HA. Development of a smartphone application for clinical-guideline-based obesity management. Healthc Inform Res. 2015 Jan;21(1):10-20. doi: 10.4258/hir.2015.21.1.10. Epub 2015 Jan 31. PubMed 25705553 ↗
  • Pretlow RA, Stock CM, Allison S, Roeger L. Treatment of child/adolescent obesity using the addiction model: a smartphone app pilot study. Child Obes. 2015 Jun;11(3):248-59. doi: 10.1089/chi.2014.0124. Epub 2015 Mar 11. PubMed 25760813 ↗
  • Vidmar AP, Pretlow R, Borzutzky C, Wee CP, Fox DS, Fink C, Mittelman SD. An addiction model-based mobile health weight loss intervention in adolescents with obesity. Pediatr Obes. 2019 Feb;14(2):e12464. doi: 10.1111/ijpo.12464. Epub 2018 Aug 16. PubMed 30117309 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 17, 2017
  • Informed consent form · Apr 25, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — The individual participant data will be de-identified and coded. The sponsor of the study will have access to this data through the application download. The data will not be available to the public.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02689154
Lead sponsor
Children's Hospital Los Angeles
Responsible party
Alaina Vidmar, MD (Pediatric Endocrinology Fellow Children's Hospital of Los Angeles, Children's Hospital Los Angeles) — Principal investigator
First posted
Feb 23, 2016
Start date
Apr 2016
Primary completion
Sep 2017
Completion
Sep 2017
Results posted
Apr 12, 2019
Last update
Apr 12, 2019

Study contacts

Steve D Mittelman, MD, PhD
study director · Children's Hospital Los Angeles

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion